Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 15,531 |
|
|||||
| News | - | ||||||
| Day High | 5.255 | Low High |
|||||
| Day Low | 5.03 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tharimmune Inc | THAR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.12 | 2.35% | 5.23 | 12:07:35 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.10 | 5.03 | 5.255 | 5.11 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 294 | 15,531 | $ 5.11 | $ 79,357 | - | 0.3008 - 9.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:08:05 | 1 | $ 5.195 | USD |
Tharimmune Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 61.4M | 11.74M | - | 0 | -9.32M | -0.79 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tharimmune News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical THAR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.36 | 5.4801 | 4.3201 | 4.99 | 39,472 | 0.87 | 19.95% |
| 1 Month | 0.411 | 5.4801 | 0.3008 | 0.6798155 | 292,383 | 4.82 | 1,172.51% |
| 3 Months | 0.3733 | 5.4801 | 0.3008 | 0.5126923 | 266,826 | 4.86 | 1,301.02% |
| 6 Months | 0.60 | 5.4801 | 0.3008 | 0.4869507 | 575,371 | 4.63 | 771.67% |
| 1 Year | 5.50 | 9.50 | 0.3008 | 3.71 | 1,298,363 | -0.27 | -4.91% |
| 3 Years | 5.50 | 9.50 | 0.3008 | 3.71 | 1,298,363 | -0.27 | -4.91% |
| 5 Years | 5.50 | 9.50 | 0.3008 | 3.71 | 1,298,363 | -0.27 | -4.91% |
Tharimmune Description
| Hillstream BioPharma Inc is a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug-resistant and devastating cancers. |
